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Talin rod domain–containing protein 1 (TLNRD1) is a
novel actin-bundling protein which promotes
filopodia formation
Alana R. Cowell1, Guillaume Jacquemet2,3, Abhimanyu K. Singh1, Lorena Varela1, Anna S. Nylund2,3, York-Christoph Ammon4, David G. Brown1,
Anna Akhmanova4, Johanna Ivaska2,5, and Benjamin T. Goult1
Talin is a mechanosensitive adapter protein that couples integrins to the cytoskeleton. Talin rod domain–containing protein
1 (TLNRD1) shares 22% homology with the talin R7R8 rod domains, and is highly conserved throughout vertebrate evolution,
although little is known about its function. Here we show that TLNRD1 is an α-helical protein structurally homologous to
talin R7R8. Like talin R7R8, TLNRD1 binds F-actin, but because it forms a novel antiparallel dimer, it also bundles F-actin. In
addition, it binds the same LD motif–containing proteins, RIAM and KANK, as talin R7R8. In cells, TLNRD1 localizes to actin
bundles as well as to filopodia. Increasing TLNRD1 expression enhances filopodia formation and cell migration on 2D
substrates, while TLNRD1 down-regulation has the opposite effect. Together, our results suggest that TLNRD1 has retained
the diverse interactions of talin R7R8, but has developed distinct functionality as an actin-bundling protein that promotes
filopodia assembly.
Introduction
Talin rod domain–containing protein 1 (TLNRD1) is an evo-
lutionarily conserved yet little studied protein that shares
homology with the cytoskeletal protein talin. TLNRD1 was
originally named mesoderm development candidate 1 (MESDC1)
because the gene, located on human chromosome 15, mapped to
the mesd locus essential for mesoderm development (Holdener
et al., 1994; Wines et al., 2001). However, this assignment proved
erroneous (Hsieh et al., 2003), and the gene was renamed
TLNRD1 (Yates et al., 2017), reflecting its similarity to the R7R8
rod domain of talin.
Talin1 and 2 are cytoplasmic adapters that provide a direct
mechanosensitive link between the integrin receptors and the
actin cytoskeleton (Calderwood et al., 2013; Goult et al., 2018).
Talins are comprised of an N-terminal FERM domain (Elliott
et al., 2010) coupled via a flexible linker to a large rod domain
comprised of 13 helical bundles, R1–R13 (Fig. 1 A; Goult et al.,
2013). 12 of the rod domains are arranged linearly, end to end, to
create the large extended talin rod that unfolds in response to
mechanical force (Yao et al., 2016). However, the R7R8 rod do-
mains adopt a unique fold, where R8, a four-helix bundle, is
inserted into a loop between two helices of the R7 five-helix
bundle (Gingras et al., 2010), creating a branch in the talin rod
(Fig. 1, A and B).
Talin R7R8 is emerging as a major signaling hub, linking
diverse cytoskeletal elements together (Goult et al., 2018). It
forms part of a major actin-binding site (actin-binding site
2 [ABS2]) that spans R4–R8 (Atherton et al., 2015; Kumar et al.,
2016; Hemmings et al., 1996). Talin R7R8 also binds to multiple
other ligands, many of which contain leucine-aspartate motifs
(LD motifs; Alam et al., 2014). R8 binds (i) Rap1-GTP–interacting
adaptor molecule (RIAM), implicated in recruitment of talin to
the leading edge of cells (Chang et al., 2014; Goult et al., 2013)
and to filopodial protrusions (Lagarrigue et al., 2015); (ii) deleted
in liver cancer 1 (DLC1; Zacharchenko et al., 2016; Li et al.,
2011); (iii) paxillin (Zacharchenko et al., 2016); and (iv) cyclin-
dependent kinase 1 (CDK1; Gough et al., 2021). R8 also contains a
binding site for vinculin (Gingras et al., 2010) and the inter-
mediate filament protein α-synemin (Sun et al., 2008). The R7
domain binds to KANK proteins (Bouchet et al., 2016; Sun et al.,
2016), which serve as platforms for the assembly of large cortical
microtubule stabilizing complexes that capture microtubules at
the periphery of integrin adhesion complexes (Bouchet et al.,
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2016). This complex protein interaction network suggests that
R7R8 plays a key role in coordinating multiple processes in-
cluding crosstalk between all three cytoskeletal networks. Mu-
tations in R7R8 have been shown to perturb this coordination
and increase invasion and migration in cells (Azizi et al., 2021).
Previous studies have shown that TLNRD1 is directly targeted
by anti-oncogenic miRNAs, with TLNRD1 overexpression being
associated with increased proliferation and xenograft growth in
hepatocellular carcinoma (Tatarano et al., 2012; Wu et al., 2017).
In contrast, TLNRD1 depletion reduced bladder cancer cell via-
bility, migration, and invasion, and data frommultiple databases
(Nagy et al., 2018) show that high TLNRD1 mRNA levels often
correlate with poor lung cancer patient survival.
Here we show that although TLNRD1 and talin R7R8 both
have the same domain structures and topology, and both bind
actin, TLNRD1 is unique in its ability to bundle F-actin. Our
structural data show that this is because it dimerizes via its four-
helix module. In U2OS cells, TLNRD1 localizes to thick actin
stress fibers and filopodial protrusions, with distinctive locali-
zation to the filopodia. TLNRD1 overexpression increases filo-
podia formation and cellular migration in 2D. Finally, we establish
biochemically that TLNRD1 can interact with known R7R8 LD
motif–containing ligands, potentially impacting their ability to
interact with talin and therefore talin function in cells.
Results
The origin of TLNRD1
Sequence homology predicts that TLNRD1 has a structure sim-
ilar to talin R7R8 with an additional N-terminal unstructured
region (residues 1–43; Fig. 1 B and Fig. S1 A). This, plus their 22%
amino acid sequence identity, suggests that TLNRD1 may have
Figure 1. TLNRD1 is homologous to talin R7R8. (A) The domain structure of talin. Talin has an N-terminal head domain and a large rod domain comprised of
13 helical bundles, R1–R13 (Goult et al., 2013). The R7 (blue) and R8 (orange) domains are highlighted. The 11 VBSs are shown in pink. (B) Schematic of talin
R7R8 (left) and TLNRD1 (right); the four-helix bundle (orange) is inserted into the loop between α3 and α8 helices of the five-helix bundle (blue). The VBS
consensus sequence (Gingras et al., 2010) in talin R7 and R8 (pink) is absent from TLNRD1. (C) Crystal structure of TLNRD1-FL reveals an antiparallel,
symmetric dimer. The domains of each monomer are labeled as 4h and 5h, and 4h’ and 5h’. (D) Top-down view of C with the helices labeled. The two four-helix
bundles dimerize via the extensive interface between helices α6 and α7. (E) Schematic representation of the TLNRD1 dimer. (F) Overlay of the TLNRD1-4H
structure (orange) on top of TLNRD1-FL (partially transparent) showing the dimerization interface is identical in both. (G) Overlay of one monomer of TLNRD1
(orange and blue) with talin R7R8 (gray; Protein Data Bank accession no. 2X0C). The individual domains are structurally homologous, but the orientation
relative to each other is different, with talin R7R8 having a more open structure.
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originated from a gene duplication event. A striking feature is
that TLNRD1 is highly conserved throughout animal evolution,
first appearing in sponges and choanoflagellates, but absent
from Cnidaria, nematodes, and arthropods (Fig. S1 B). While the
R7R8 domains of the two mammalian talin isoforms are each
encoded by 11 exons, the TLNRD1 gene consists of a single large
exon, suggesting that it may have originated from a section of
talin mRNA inserted back into an ancestral genome.
Crystal structure of TLNRD1
To determine the extent of the structural similarity between
TLNRD1 and talin R7R8, we used x-ray crystallography to solve
the structures of both full-length TLNRD1 (TLNRD1-FL) and the
four-helix domain (TLNRD1-4H). This confirmed that TLNRD1
consists of a nine-helix module comprised of a four-helix and
five-helix bundle connected via the same unusual domain link-
age identified in talin R7R8, where the four-helix bundle (R8) is
inserted into a loop between helices α3 and α4 of the five-helix
bundle (R7; Fig. 1, C–F). The first 40 residues of TLNRD1-FL are
not visible in the density, supporting the secondary structure
prediction that the N-terminal region is unstructured.
TLNRD1 is a symmetric antiparallel dimer mediated by the
four-helix bundle
Our previous gel filtration analysis suggested that TLNRD1 is a
dimer (Gingras et al., 2010). The TLNRD1 structures reveal the
basis for TLNRD1 dimerization, which is mediated by a novel
interface on the four-helix bundle. In both the TLNRD1-FL and
TLNRD1-4H structures, the four-helix bundle forms an exten-
sive interaction with a four-helix bundle of a second TLNRD1
molecule (Fig. 1, C–F). An identical dimer interface was observed
in both the TLNRD1-FL and the TLNRD1-4H structures (Fig. 1 F),
which crystallized in different space groups (Table S1). Analysis
of the macromolecular interface using PISA (Krissinel and
Henrick, 2007) verified that this was a bona fide dimer.
Dimerization of TLNRD1 is mediated via an extensive hy-
drophobic interface on helices α6 and α7, with the two F250 side
chains docking into the opposing molecule (Fig. 2, A and B). The
surface of each four-helix bundle has a pocket created by F270’
and the small side chains of G217’ and A260’ that the F250 aro-
matic rings docks into (Fig. 2 B). As it is a symmetric dimer, the
F250’ docks into the equivalent pocket on the other molecule,
leading to an antiparallel configuration. The interface is capped
at either end by electrostatic interactions between the side
chains of E267 and R246’ and vice versa. Analysis of TLNRD1
conservation using the program ConSurf (Ashkenazy et al., 2016)
reveals that these residues are highly conserved (Fig. S1 C).
We used size-exclusion chromatography multi-angle light
scattering (SEC-MALS) to explore the oligomeric state of
TLNRD1 in solution. Both TLNRD1-FL (labeled “a” in Fig. 2 C) and
TLNRD1-4H were dimeric at 25°C, and no monomer peak was
present with either construct, suggesting a high-affinity dimer
(Fig. 2, C and D). TLNRD1-FL also showed a smaller tetramer
peak (labeled “b” in Fig. 2 C), suggesting the presence of a dimer
of dimers species. To explore the importance of F250 in dimer-
ization, we generated a point mutant of F250 that swapped the
aromatic ring for a charged aspartate, F250D (TLNRD1-F250D).
The TLNRD1-F250D mutant was a stable, folded protein suit-
able for biochemical analyses as judged by circular dichroism
(CD; Fig. S2 A), nuclear magnetic resonance (NMR; Fig. S2 B),
and SEC (Fig. 2 C), although the melting temperature, Tm, de-
termined using CD, was reduced (TLNRD1-FL Tm 69.7°C, TLNRD1-
F250D Tm 48°C; Fig. S2 C). Analysis of the F250D mutant using
SEC-MALS showed a clear transition from a dimeric to mono-
meric state (peak “c”), with only a small proportion remaining as a
dimer (peak “d”), confirming the importance of F250 in mediating
dimerization.
The absence of a TLNRD1 monomer peak on SEC-MALS
suggests that dimerization is mediated by a high-affinity inter-
action. We therefore used microscale thermophoresis (MST) to
study the monomer-dimer equilibrium. MST is an established
biochemical assay for studying dimerization (Seidel et al., 2013;
Lin et al., 2012). In this experiment, unlabeled TLNRD1-FL was
titrated against fluorescently tagged TLNRD1-FL and an appar-
ent equilibrium dimer dissociation constant (Kd,dimer) of 80 nM
obtained (Fig. 2 E). MST confirmed that the F250D mutant
prevented dimerization, as no Kd was generated. The high af-
finity suggests that TLNRD1 exists as an obligate dimer, and the
F250D mutant renders TLNRD1 monomeric.
TLNRD1 retains the functionality of talin R7R8
Given the diverse talin R7R8 interactome, we asked whether
TLNRD1 binds the same ligands. We first tested RIAM and
KANK1 as both contain well-defined LDmotif talin binding sites,
with RIAM binding to talin R8, and KANK to R7. Fluorescence
polarization studies showed that TLNRD1-FL (Fig. 3 A) interacts
with RIAM (residues 4–30) with a Kd of 0.25 µM (Fig. 3 B), more
tightly than talin R7R8 (Fig. 3 D). TLNRD1-4H bound to RIAM
with similar affinity (Kd 0.59 µM; Fig. 3 C), confirming the RIAM
interaction is mediated by the four-helix domain. Furthermore,
TLNRD1-F250D also bound RIAM, confirming the integrity of
the LD binding surface on the four-helix domain in the mono-
meric form (Fig. S2 D). Lamellipodin, a paralogue of RIAM, also
interacted with TLNRD1-4H, albeit with lower affinity (Kd 9 µM;
Fig. 3 C).
The KANK1 “KN domain” LDmotif (residues 30–60) bound to
TLNRD1-FL (Kd 11.6 µM; Fig. 3 E), albeit with substantially lower
affinity than talin R7R8 (Kd 0.35 µM; Fig. 3 G). KANK1 binding to
talin R7 requires the LDLD sequence in the KN domain, with a
quadruple mutation to alanine (KANK1-4A) abolishing binding.
Similarly, this KANK1-4A mutant reduced binding to TLNRD1-
FL, confirming the interaction is LD-dependent. Last, no inter-
action was observed between KANK1 and TLNRD1-4H (Fig. 3 F),
confirming the TLNRD1-KANK1 interaction is mediated via the
five-helix module. The structural information from equivalent
talin complexes was used to model the RIAM- and KANK-binding
sites onto the TLNRD1-FL structure (Fig. 3 H). Collectively,
this biochemical analysis confirms that TLNRD1 has retained
the LD binding sites in both the four- and five-helix modules,
and by inference, that talin was able to bind LD motifs before
the duplication event.
Another major role of talin R7R8 is to bind actin (Hemmings
et al., 1996), and TLNRD1 has previously been shown to bind
actin (Gingras et al., 2010). Using a high-speed cosedimentation
Cowell et al. Journal of Cell Biology 3 of 12
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assay, we confirmed that TLNRD1-FL interacts with actin fila-
ments (Fig. 3 I). Furthermore, we found that TLNRD1-4H alone
interacts tightly with actin (Fig. 3 I). This is surprising as, by
itself, the equivalent four-helix module in talin, R8, shows little
actin binding in cosedimentation assays (Gingras et al., 2010),
suggesting that TLNRD1 has enhanced actin filament binding.
Taken together, these data indicate that TLNRD1 is an actin-
binding protein that has retained functional similarities to
talin R7R8.
TLNRD1 is an actin-bundling protein
In talin, ABS2 maps to domains R4–R8, with the two four-helix
bundles, R4 and R8, engaging the actin filament (Fig. 4 A;
Atherton et al., 2015). The actin-binding surface on R8 maps
onto one face (helices α2 and α3) of the bundle. Our initial hy-
pothesis was that as TLNRD1 was a dimer, it might engage a
single actin filament in a similar fashion to talin ABS2. However,
the structure of TLNRD1 revealed that the putative actin-binding
surfaces on α2 and α3 are positioned facing away from the dimer
interface (Fig. 4 A), raising the possibility that TLNRD1 might
engage two actin filaments simultaneously, and thus cross-link
and bundle actin.
To establish whether TLNRD1 is also an actin-bundling pro-
tein, we used a low-speed (10,000 rpm) cosedimentation assay
where actin filaments remain in the supernatant and only
bundled actin filaments sediment. Addition of TLNRD1-FL re-
sulted in a clear increase in the levels of actin in the low-speed
pellet, confirming that TLNRD1 is an actin bundler (Fig. 4 B). In
contrast, neither talin R7R8, nor ABS2, which are both mono-
meric, is able to bundle actin (Atherton et al., 2015). Given the
discovery that TLNRD1-4H can bind actin filaments (Fig. 3 I),
we tested the ability of TLNRD1-4H to bundle actin, and surpris-
ingly, we found that the four-helix domain alone is an effective
actin bundler (Fig. 4 C and Fig. S2 E). To confirm TLNRD1 bun-
dling activity, actin filaments were visualized by negative stain
EM both in the absence (Fig. S2 F) or presence of TLNRD1-FL,
Figure 2. Characterization of the TLNRD1 dimer. (A and B) The symmetrical antiparallel TLNRD1 dimer interface mediated by F250. One monomer is
shown as a white surface representation, F250 from the opposing monomer (orange) inserts into the pocket on the surface of the other. A salt bridge between
R246 and E267’ is shown. (C and D) SEC-MALS analysis of 106 µM TLNRD1-FL WT (black) and F250D (red). (D) Analysis of the molar mass of the major
TLNRD1-FL species “a” yields a molecular weight of ∼74 kD. The TLNRD1-F250D yields a molecular weight of ∼37.8 kD, peak “c.” (E) TLNRD1-FL dimerization
measured using MST at 25°C with 40% Red LED laser excitation. Unlabeled TLNRD1-FL was titrated into a fixed concentration (50 nM) of fluorescently labeled
TLNRD1-FL. Data were analyzed in MO.Affinity Analysis software (v2.1.3) using the law of mass action to generate an apparent equilibrium dimer Kd, Kd,dimer of
80 ± 0.6 nM. F250D Kd,dimer not determined. FNorm, normalized fluorescence; ND, not defined.
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TLNRD1-4H, and TLNRD1-F250D (Fig. 4, D–F). This revealed that
TLNRD1-FL can form large bundles of actin filaments with tight
inter-filament spacing and that the 4H domain alone is sufficient
for bundling. Similarly, TLNRD1 was found to decorate actin
stress fibers when expressed as N-terminally GFP-tagged (GFP-
TLNRD1) in U2OS cells (Fig. 4 and Video 1).
A key feature that distinguishes TLNRD1 from talin R7R8
is its dimeric state. To explore the importance of TLNRD1 di-
merization in promoting bundling of actin filaments, actin
cosedimentation assays were performed with the monomeric
TLNRD1-F250D. TLNRD1-F250D was still able to bind to actin
filaments (Fig. S2 G), but it showed significantly reduced actin-
bundling activity (Fig. S2 H), confirming that dimerization is
required for TLNRD1 to bundle actin effectively. This loss of bun-
dlingwas visualized by EM,where themonomeric TLNRD1-F250D
decorates actin filaments (Fig. 4 F) but can no longer bundle them.
In summary, TLNRD1 binds actin considerably more tightly than
talin R7R8 or ABS2, and also bundles actin.
TLNRD1 promotes filopodia formation and modulates
cell migration
As actin-bundling proteins contribute to filopodia func-
tions (Gupton and Gertler, 2007; Khurana and George, 2011;
Jacquemet et al., 2015), we wondered whether TLNRD1 might
also modulate filopodia formation. Overexpression of GFP-
TLNRD1 in U2OS promoted MYO10-positive filopodia forma-
tion, whereas the expression of GFP-TLNRD1-F250D did not,
indicating that TLNRD1 dimerization is required to promote
filopodia formation (Fig. 5, A and B). Conversely, silencing
TLNRD1 expression using two independent siRNAs (Fig. 5, C
and D) led to a decrease in the number of MYO10 filopodia in
U2OS cells (Fig. 5 E).
To validate that TLNRD1 also modulates filopodia in the ab-
sence of MYO10 overexpression, two models of endogenous
filopodia formation were tested. These include (i) U2OS cells
actively spreading on fibronectin, and (ii) RAT-2 cells, which
readily generate numerous endogenous filopodia (Jacquemet
et al., 2019). In both cases, overexpression of TLNRD1 led to a
significant increase in filopodia number, while the monomeric
mutant TLNRD1-F250D failed to influence filopodia in either cell
type (Fig. 5, F–I), indicating that the ability of TLNRD1 to induce
filopodia is not secondary to MYO10 overexpression. Imaging
GFP-TLNRD1 together with MYO10 showed that TLNRD1 lo-
calized to filopodia (Fig. 5 A). To gain further insights into the
spatial distribution of TLNRD1 and MYO10 filopodia, cells
were imaged using structured-illumination microscopy (Fig.
S3, A and B). Surprisingly, these experiments revealed that
TLNRD1, unlike other filopodia bundling proteins such as fascin,
Figure 3. TLNRD1 and talin R7R8 both bind LD motif proteins and actin. (A) Schematics of TLNRD1-FL, TLNRD1-4H, and talin R7R8 domain structures.
(B–G) TLNRD1 binds to LD motif–containing ligands. (B–D) Binding of fluorescein-labeled RIAM(4–30) peptide with (B) TLNRD1-FL, (C) TLNRD1-4H, and (D)
talin R7R8 measured using a fluorescence polarization assay. The binding of lamellipodin (20–46; blue) is also shown. (E–G) BODIPY-labeled KANK1(30–60);
wild-type (black) and 4A mutant (blue) peptides (E) binding to TLNRD1-FL, (F) not binding to TLNRD1-4H, and (G) binding to talin R7R8. ND, not defined.
Experiments performed in triplicate. (H) Structural model of TLNRD1-FL bound to RIAM (cyan) and KANK (pink) LD motifs. (I) High-speed actin cosedi-
mentation assay showing that both TLNRD1-FL and TLNRD1-4H interact with F-actin. TLNRD1-4H alone does not pellet. S/N, supernatant; P, pellet.
Cowell et al. Journal of Cell Biology 5 of 12
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accumulates to MYO10 filopodia tips. Altogether, our data dem-
onstrate that TLNRD1 is a filopodia protein that modulates
filopodia formation. Finally, the effect of TLNRD1 on cell mi-
gration was assessed using live-cell imaging of U2OS cells plated
on fibronectin. This revealed that expression of GFP-TLNRD1
significantly increased migration velocity compared with non-
transfected, or GFP-expressing, cells (Fig. S3 C).
Conclusions
TLNRD1 shares high sequence and structural similarity with the
R7R8 region of talin, an important signaling hub that coordinates
multiple cellular pathways. In this work, we have characterized
TLNRD1 as a novel actin-bundling protein that supports for-
mation of filopodia.
Talin R7R8 has multiple roles, binding to actin and coupling
talin to several ligands containing LD motifs. Here we show that
TLNRD1 retains the capacity to bind actin and the LD proteins
RIAM and KANK. However, it lacks the vinculin binding site
(VBS) found in talin R7R8. Given the high similarity between
talin R7R8 and TLNRD1, TLNRD1might act as a dominant-negative
modulator of talin function, fine-tuning talin signaling responses
by sequestering R7R8 ligands and thus uncoupling them from
their connection to integrin-mediated adhesion complexes. We
also demonstrate that TLNRD1 is an obligate dimer with a mode of
Figure 4. TLNRD1 is an actin-bundling protein. (A) Schematic of talin ABS2 binding a single actin filament (left). TLNRD1-FL (middle) and TLNRD1-4H (right)
bind two actin filaments. (B and C) Actin bundling assays using serial dilutions of TLNRD1-FL (B) and TLNRD1-4H (C) against 15 µM F-actin. (D–F) EM images of
negative-stained F-actin bundles with (D) TLNRD1-FL, (E) TLNRD1-4H, and (F) TLNRD1-F250D. Red box (left) enlarged on right. (G) U2OS cells expressing GFP-
TLNRD1 were plated on fibronectin, incubated for 2 h with SiR-actin to label the actin cytoskeleton, and imaged live using an Airyscan confocal microscope
(1 picture every 16 s; Video 1). Scale bars: (main) 25 µm, (inset) 5 µm. The yellow arrows highlight GFP-TLNRD1 localizing to actin stress fibers.
Cowell et al. Journal of Cell Biology 6 of 12
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Figure 5. TLNRD1 localizes to, and modulates, filopodia. (A and B) U2OS cells transiently expressing MYO10-mScarlet and GFP, GFP-TLNRD1, or GFP-
TLNRD1-F250D were plated on fibronectin for 2 h, fixed, and imaged using a spinning disk confocal microscope. Representative images are displayed (A).
Yellow square indicates region of interest, which is magnified on the right. Scale bars: (main) 25 µm, (inset) 5 µm. (B) The number of MYO10-positive filopodia
per cell was then quantified (n > 125 cells, three biological repeats; ***, P = 0.002). (C and D) Efficiency of siRNA-mediated (oligos nos. 6 and 7) silencing of
TLNRD1 in U2OS cells as detected using quantitative PCR (C) or Western blotting (D). To detect TLNRD1 protein levels by Western blot, TLNRD1 was first
immuno-precipitated from cell lysate as indicated. (E) TLNRD1-silenced (oligos nos. 6 and 7) U2OS cells transiently expressing MYO10-GFP were plated on
fibronectin for 2 h and fixed, and the number of MYO10-positive filopodia per cell was quantified (n > 150 cells, three biological repeats; ***, P < 0.001).
(F and G) U2OS cells transiently expressing GFP, GFP-TLNRD1, or GFP-TLNRD1-F250D were plated on fibronectin for 20 min, fixed, and imaged using an
Airyscan confocal microscope. Scale bars: (main) 10 µm, (inset) 5 µm. (G) The number of endogenous filopodia per cell was quantified (n > 108 cells, three
biological repeats; ***, P < 0.001). (H and I) RAT-2 cells transiently expressing GFP, GFP-TLNRD1, or GFP-TLNRD1-F250D were plated on fibronectin for 2 h,
Cowell et al. Journal of Cell Biology 7 of 12
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actin binding distinct from talin ABS2. The orientation of the two
TLNRD1 monomers with respect to actin allows the dimeric pro-
tein to efficiently bundle actin. Together, this suggests that
TLNRD1 has similar and distinct functions to talin R7R8.
Talin R7R8 is buried in the autoinhibited form of the mole-
cule (Dedden et al., 2019), and is exposed upon talin activation at
adhesion sites. As TLNRD1 lacks these additional domains, it
might be constitutively active (Fig. 3 H). However, a notable
feature of the TLNRD1-FL structure is that the five-helix bundle
packs against the side of the four-helix bundle. We observe a
similar compact conformation in solution (Fig. S2, I and J). In
contrast, multiple structures of talin1 R7R8 solved alone (Gingras
et al., 2010) and in complex (Chang et al., 2014; Zacharchenko
et al., 2016; Gough et al., 2021) show no equivalent interactions
between R7 and R8. Thus, it is possible that this more compact
conformation might represent an autoinhibited conformation of
TLNRD1, rendering some binding sites cryptic.
Importantly, we report that TLNRD1 dimers but not mono-
mers localize to and regulate filopodia formation (Fig. 5). As
TLNRD1 dimers bundle actin, and as actin bundlers have a well-
characterized role in inducing filopodia (Gupton and Gertler,
2007; Khurana and George, 2011; Jacquemet et al., 2015), it is
tempting to speculate that TLNRD1 promotes filopodia forma-
tion via its actin-bundling property. As filopodia often contrib-
ute to invasive migration of cancer cells (Jacquemet et al., 2015,
2017), and as increased TLNRD1mRNA levels correlate with poor
outcomes in lung cancer (Nagy et al., 2018), future work will
focus on the contribution of TLNRD1 to invasive cell migration.
In summary, we have structurally and biochemically char-
acterized the TLNRD1 protein as a novel actin-bundling protein
that can drive filopodia formation and cell migration. In doing
so, we have expanded both the talin family of proteins with the
identification of a third talin gene and the growing set of pro-
teins that can polymerize actin filaments into bundles.
Materials and methods
Constructs for biochemical/structural assays
Human TLNRD1 (TLNRD1-FL, residues 1–362) pET151 was pur-
chased as a codon-optimized synthetic gene from GeneArt.
TLNRD1-4H (residues 143–273) was sub-cloned into pET151 vector.
Single point mutations were introduced into TLNRD1 using site-
directed mutagenesis with Pfu DNA polymerase (Promega), fol-
lowed by digestion with DpnI at 37°C for 1 h and transformation
into DH10β Escherichia coli cells.
All expression constructs have been deposited in Addgene at
http://www.addgene.org/ben_goult.
Protein expression and purification
TLNRD1 constructs were expressed in BL21(DE3) E. coli cells
grown in lysogeny broth at 37°C with 100 µg/ml ampicillin.
Expression was induced with 0.1 mM IPTG and cells further
incubated at 18°C overnight. Proteins were purified using stan-
dard techniques (Khan et al., 2021). Briefly, following centrifu-
gation, pelleted cells were resuspended in nickel affinity buffer
(50 mM imidazole, 500 mM NaCl, and 20 mM Tris-HCl, pH 8).
Cell lysates were loaded onto a 5-ml HisTrap HP column (GE
Healthcare) for purification by nickel affinity chromatography.
Eluted protein was exchanged into MES buffer (20 mM 2-N-
morpholinoethanesulfonic acid, 20 mM NaCl, and 2 mM DTT,
pH 6.5). His-tags were removed with AcTEV protease (Invitrogen)
overnight and proteins further purified with a HiTrap SP HP
cation exchange column (GE Healthcare).
Fluorescence polarization assay
The following peptides with a C-terminal cysteine residue were





Assays were performed with a serial dilution of protein, with
target peptides at a concentration of 100 nM. Peptides were
coupled with either a fluorescein or BODIPY-TMR dye (Thermo
Fisher Scientific). Fluorescence polarization was measured us-
ing a CLARIOstar plate reader (BMGLabTech) at 20°C. Data were
analyzed using GraphPad Prism 7 software and Kd values gen-
erated with the one-site total binding equation.
F-actin cosedimentation assays
Actin was isolated from rabbit muscle acetone powder kindly
gifted by Professor Mike Geeves (University of Kent, UK) and
prepared using a cycle of polymerization and depolymerization
following the protocol of Spudich and Watt (1971). Briefly, 1.5 g
of acetone powderwas stirred on ice in prechilled buffer (10mM
Tris, 1 mM DTT, 0.5 mM ATP, and 0.2 mM CaCl2, pH 8) for
30min, filtered, and spun at 30,000 rpm for 1 h at 4°C. The actin
was polymerized by adding KCl to a final concentration of
100 mM followed by MgCl2 to a final concentration of 2 mM and
stirred at room temperature for 1 h. The polymerized actin was
then pelleted by centrifugation at 30,000 rpm at 4°C for 3 h
before being resuspended in depolymerizing buffer (5 mM Tris,
1 mM NaN3, and 0.2 mM CaCl2, pH 7.5) by homogenization and
dialyzed into the same buffer overnight at 4°C. The dialyzed
depolymerized actin was centrifuged the next day at 30,000 rpm
at 4°C for 1 h to remove sediments and diluted to a concentration
of 1 mg/ml. Final purified F-actin was stored at 4°C in poly-
merization buffer (10 mM Tris-HCl, pH 7, 50 mM NaCl, 2 mM
MgCl2, 1 mMNaN3, and 1 mMDTT). For cosedimentation assays,
F-actin was diluted to 15 µM and incubated with a serial dilution
of protein starting at a 1:1 ratio for 1 h at room temperature. To
test binding, samples were spun at 100,000 × g for 20min at 4°C.
To test bundling activity, samples were spun at 10,000 × g for
15 min at 4°C. Equal volumes of pellet and supernatant were
fixed, and imaged using a spinning disk confocal microscope. Scale bars: (main) 20 µm, (inset) 5 µm. (I) The number of endogenous filopodia per cell was
quantified (n > 129 cells, four biological repeats; ***, P < 0.001). P values were determined using a randomization test (see Materials and methods for details).
siCTRL, siRNA used as control.
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loaded onto SDS-PAGE gels and densities analyzed using ImageJ
software (Schneider et al., 2012).
Negative stain EM
Human F-actin (cat. no. APHL99-E; Cytoskeleton) was diluted to
23 µM in polymerization buffer. TLNRD1-FL, TLNRD1-4H, and
TLNRD1-F250D were incubated with F-actin at a 1:1 ratio over-
night at 4°C. After incubation, samples were diluted down to
1 µM with polymerization buffer. Samples were applied to 400
mesh carbon-coated copper grids for 30 s and negatively stained
for 30 s with 2% (wt/vol) uranyl acetate. Excess stain was re-
moved and grids air-dried. Images were taken on an FEI Tecnai
T12 EM equipped with a Gatan US4000 CCD detector and ac-
celerating voltage of 120 kV.
SEC-MALS
SEC-MALS analysis of TLNRD1-FL and TLNRD1-F250D mutant
was performed at room temperature with 100 µl of protein at
150 µM. Samples were loaded onto a Superdex 75 size-exclusion
column (GEHealthcare Life Sciences) and eluted proteinsmeasured
by Viscotek Sec-Mals 9 and Viscotek R1 detector VE3580 (Malvern
Panalytical). Data were analyzed using OmniSEC software.
Crystallization, x-ray data collection, and structure solution
TLNRD1-FL and TLNRD1-4H crystallization trials were per-
formed using hanging drop vapor diffusion at 21°C with
concentrations of 390 µM and 350 µM, respectively. Crys-
tals of TLNRD1-FL were obtained in a condition containing
250 mM NaSCN and 20% PEG3350 and grown to optimal size
in 7 d. For TLNRD1-4H, crystals were obtained in 300 mM
HOC(CO2H)(CH2CO2NH4)2 and 25% PEG3350 and attained full
growth in 4 d. Crystals were harvested in their respective
growth solutions supplemented with 25% ethylene glycol as
cryoprotectant, mounted on CryoLoops (Hampton Research) or
LithoLoops (Molecular Dimensions), and vitrified in liquid ni-
trogen for data collection. x-ray diffraction datasets were col-
lected at 100 K at Proxima-1 beamline at Soleil Synchrotron
using a Pilatus 6M detector (Dectris) and processed by an
autoPROC pipeline (Vonrhein et al., 2011), which incorporates
XDS (Kabsch, 2010), AIMLESS (Evans and Murshudov, 2013),
and TRUNCATE (Evans, 2011) for data integration, scaling, and
merging, respectively. The structure of TLNRD1-4H was deter-
mined bymolecular replacement performed by PHASER (McCoy
et al., 2007) using Protein Data Bank accession no. 2X0C (Gingras
et al., 2010) as a search model. For the TLNRD1-FL solution,
BALBES molecular replacement pipeline (Long et al., 2008) was
employed to generate the initial model, which was then manu-
ally tweaked before adjustment and refinement. Manual model
adjustment was performed in COOT (Emsley et al., 2010)
followed by refinement using PHENIX.REFINE (Afonine et al.,
2012). TLNRD1-FL (Protein Data Bank accession no. 6XZ4) was
diffracted to 2.3 Å in P21 space group with two TLNRD1 mol-
ecules in the asymmetric unit, and TLNRD1-4H (Protein Data
Bank accession no. 6XZ3) to 2.2 Å in I4122 space group with
one molecule in the asymmetric unit (statistics in Table S1).
For TLNRD1-FL, electron density could be traced for residues 40–341,
and for TLNRD-4H, residues 148–270. Interaction properties of
the dimer interface of the TLNRD1-FL were assessed by PISA
(Krissinel and Henrick, 2007), and figures were prepared in
PyMOL (Schrödinger LLC). Models were validated by MOL-
PROBITY (Chen et al., 2010) before deposition.
SEC-small angle x-ray scattering (SAXS)
SEC-SAXS data were collected at Diamond Light Source beam-
line B21 (Didcot). TLNRD1-FL SAXS experiments were per-
formed at 80 µM and 185 µM in 20 mM Tris, pH 7, 50 mMNaCl,
and 2 mM DTT. All samples were loaded onto a KW-403-4F
10–600 kD size-exclusion column (Shodex) connected to an
Agilent 1200 HPLC system. Data were analyzed using ScÅtter
software available from http://www.bioisis.net and ATSAS on-
line services (Franke et al., 2017).
Microscale thermophoresis
For investigations into dimerization, His-tagged TLNRD1 was
diluted to 100 nM and coupled with His-tag NT-647 dye (RED-
tris-NTA; NanoTemper) at room temperature for 30 min. Un-
labeled non–His-tagged TLNRD1was diluted down to 5 µM. Final
working concentrations of labeled and unlabeled protein were
50 nM and 2.5 µM, respectively, with the unlabeled protein
serially diluted. Samples were loaded into Monolith NT.115 Capil-
laries and run on a Monolith NT.115 (NanoTemper). All experi-
ments were run at 25°C with 40% laser excitation. Data were
analyzed using MO.Affinity Analysis v2.3.
Cell culture
For cell culture experiments, N-terminal GFP-tagged mouse
TLNRD1was used as previously described (Gingras et al., 2010). The
mScarlet-MYO10 construct was described previously (Jacquemet
et al., 2019). Human U2OS osteosarcoma cells (Leibniz Institute
DSMZ-GermanCollection ofMicroorganisms andCell Cultures) and
RAT-2 cells (CRL-1764; American Type Culture Collection) were
grown in DMEM supplemented with 10% FCS, 2 mM L-glutamine,
and 1% (vol/vol) penicillin and streptomycin, and maintained at
37°C in a humidified 5% CO2 environment.
Transfection and siRNA knockdown
Plasmids of interest were transfected using Lipofectamine 3000
and the P3000TM Enhancer Reagent (Thermo Fisher Scientific)
according to the manufacturer’s instructions. The expression of
proteins of interest was suppressed using 100 nM siRNA and
Lipofectamine 3000 (Thermo Fisher Scientific) according to the
manufacturer’s instructions. The siRNA used as control was Allstars
negative control siRNA (cat. no. 1027281; QIAGEN). The siRNAs
targeting TLNRD1 were purchased from QIAGEN (siTLNRD1#6,
Hs_MESDC1_6 FlexiTube siRNA, cat. no. SI04217605; siTLNRD1
#7, Hs_MESDC1_7 FlexiTube siRNA, cat. no. SI04314569; and
siTLNRD1#8, Hs_MESDC1_8 FlexiTube siRNA, cat. no. SI04362820).
TLNRD1 immunoprecipitation
For immunoprecipitation experiments, U2OS cells were grown
to 90% confluency in a 100-mm dish and lysed with equal vol-
umes of appropriate buffer (40mMHepes-NaOH, pH 7.4, 75mM
NaCl, 2 mM EDTA, and 2% NP-40). Lysates were cleaned by
centrifugation at 10,000 × g for 5 min at 4°C before 3 h incubation
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at 4°C with Dynabeads Protein G superparamagnetic beads pre-
coated with anti-TLNRD1 antibody or IgG control. Beads were
washed three times with PBS. Protein extracts were separated
under denaturing conditions by SDS-PAGE and subjected to
Western blotting with appropriate primary antibody diluted 1:
1,000 followed by incubation with the appropriate fluorophore-
conjugated secondary antibody diluted 1:5,000. Membranes
were scanned using an Odyssey infrared imaging system (LI-
COR Biosciences).
Anti-TLNRD1 antibodies were raised in rabbit against re-
combinantly expressed human TLNRD1 (residues 1–362) by Capra
Science. The secondary antibody used for Western blot was an
IRDye 800CW conjugated donkey anti-rabbit antibody (cat. no.
926–32213; Li-Cor).
Sample preparation for light microscopy
For structured illumination microscope (SIM) imaging, U2OS
cells transiently expressing GFP-TLNRD1 and Myosin-X-
mScarlet were plated on high-tolerance glass-bottom dishes
(coverslip no. 1.7; MatTek Corporation) precoated first with
poly-L-lysine (10 mg/ml, 1 h at 37°C) and then with bovine
plasma fibronectin (10 mg/ml, 2 h at 37°C). After 2 h, samples
were fixed and permeabilized simultaneously using a solution
of 4% (wt/vol) PFA and 0.25% (vol/vol) Triton X-100 for 10 min.
Cells were then washed with PBS, quenched using a solution of 1 M
glycine for 30 min, and incubated with silicon rhodamine (SiR)-
actin (100 nM in PBS; cat. no. CY-SC001; Cytoskeleton) at 4°C until
imaging (minimum length of staining, overnight at 4°C; maximum
length, 1wk). Just before imaging, sampleswerewashed three times
in PBS and mounted in Vectashield (Vectorlabs).
To map the localization of each protein within filopodia,
images were first processed in Fiji (Schindelin et al., 2012) and
data analyzed using R as previously described (Jacquemet et al.,
2019). Briefly, in Fiji, the brightness and contrast of each image
were automatically adjusted using, as an upper maximum, the
brightest cellular structure labeled in the field of view. In Fiji,
line intensity profiles (1 pixel width) were manually drawn
from filopodium tip to base (defined by the intersection of the
filopodium and the lamellipodium). To avoid any bias in the
analysis, the intensity profile lines were drawn from a merged
image. All visible filopodia in each image were analyzed and
exported for further analysis (export was performed using the
‘‘Multi Plot’’ function). For each staining, line intensity profiles
were then compiled and analyzed in R. To homogenize filopodia
length, each line intensity profile was binned into 40 bins
(using the median value of pixels in each bin and the R function
‘‘tapply’’). Using the line intensity profiles, the percentage of
filopodia positive for each protein of interest was quantified.
The map of each protein of interest was created by averaging
hundreds of binned intensity profiles.
For the filopodia formation assays, cells were plated on
fibronectin-coated glass-bottom dishes (MatTek Corporation) as
indicated. Samples were fixed for 10 min using a solution of 4%
(wt/vol) PFA, then permeabilized using a solution of 0.25% (vol/
vol) Triton X-100 for 3 min. Cells were then washed with PBS
and quenched using a solution of 1 M glycine for 30 min. Samples
were thenwashed three times in PBS and stored in PBS containing
SiR-actin (100 nM; cat. no. CY-SC001; Cytoskeleton) at 4°C until
imaging. Just before imaging, samples were washed three times in
PBS. Images were acquired using either a spinning disk confocal
microscope (100× objective) or an Airyscan confocal microscope
(63× objective). Samples were kept in PBS and imaged at room
temperature. The number of filopodia per cell and their length
were manually counted using Fiji (Schindelin et al., 2012).
Microscopy setup
The spinning disk confocal microscope used was a Marianas
spinning disk imaging system with a Yokogawa CSU-W1 scan-
ning unit on an inverted Zeiss Axio Observer Z1 microscope
controlled by SlideBook 6 (Intelligent Imaging Innovations, Inc.).
Images were acquired using a Photometrics Evolve, a back-
illuminated EMCCD camera (512 × 512 pixels), and a 100× (NA
1.4 oil, Plan-Apochromat, M27) objective.
The confocal microscope used was a laser scanning confocal
microscope LSM880 (Zeiss) equipped with an Airyscan detector
(Carl Zeiss) and a 40× oil (1.2) or 63× oil (1.4) objective. The
microscope was controlled using Zen Black (2.3), and the Airy-
scan was used in standard super-resolution mode. Fixed samples
were kept in PBS and imaged at room temperature. Live samples
were kept in their growing media supplemented by 50 mM of
Hepes and imaged at 37°C in the presence of CO2.
The SIM used was DeltaVision OMX v4 (GE Healthcare Life
Sciences) fitted with a 60× Plan-Apochromat objective lens, 1.42 NA
(immersion oil refractive index of 1.516) used in SIM illumination
mode (five phases × three rotations). Emitted lightwas collected on a
front-illuminated pco.edge sCMOS (pixel size 6.5mm, readout speed
95 MHz; PCO AG) controlled by SoftWorx. Samples were mounted
in Vectashield (Vectorlabs) and imaged at room temperature.
2D random migration assay
Cells were seeded at a density of 5 × 103 in 1 ml media supple-
mented with 50 mM Hepes on plates coated with 10 µg/ml fi-
bronectin and incubated for 2 h at 37°C, 5% CO2. Live cell
imaging was performed on a Nikon Eclipse Ti2-E widefield mi-
croscope with a heated CO2 chamber, Hamamatsu scientific CMOS
Orca Flash 4 v4, and 10× Nikon CFI Plan Fluor objective. Random
migration of cells was measured over 24 h in a time-lapse video
with images taken every 10 min. Manual tracking of cells was
performed using Fiji ImageJ MTrackJ plugin. The tracked data were
analyzed using Ibidi chemotaxis and migration tool to determine
migration speeds, directionality, and distance. Graphs of resulting
datawere produced using PlotsOfData (Postma andGoedhart, 2019).
Quantification and statistical analysis
Randomization tests were performed using the online tool PlotsOf-
Differences (https://huygens.science.uva.nl/PlotsOfDifferences/;
Goedhart, 2019). Dot plots were generated using PlotsOfData
(Postma and Goedhart, 2019).
Quantitative RT-PCR
Total RNA extracted using the NucleoSpin RNA Kit (Macherey-
Nagel) was reverse-transcribed into cDNA using the high-
capacity cDNA reverse transcription kit (Applied Biosystems)
according to themanufacturer’s instructions. The RT-PCR reactions
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were performed using predesigned single tube TaqMan gene ex-
pression assays and were analyzed with the 7900HT fast RT-PCR
System (Applied Biosystems). Data were studied using RQ Manager
Software (Applied Biosystems). TLNRD1 primers were fromThermo
Fisher Scientific (cat. no. 4351372; probe ID Ss06942862_s1).
Online supplemental material
Fig. S1 shows the conservation of TLNRD1 and its alignment with
talin R7R8 domains. Fig. S2 shows biochemical analysis of
TLNRD1 and the characterization of the TLNRD1-F250D mu-
tant. Fig. S3 shows the sub-filopodial localization of TLNRD1 in
MYO10 filopodia and the role of TLNRD1 in migrating cells.
Video 1 shows that TLNRD1 can localize to actin fibers in living
cells. Table S1 lists the crystallographic data collection and re-
finement statistics for TLNRD1-FL and TLNRD1-4H.
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Figure S1. Conservation of TLNRD1 and its alignment with talin R7R8 domains. (A) Amino acid sequence alignment of human TLNRD1 (UniProt accession
no. Q9H1K6) and talin1 residues 1357–1653 encompassing R7R8 (UniProt accession no. Q9Y490). Domain boundaries are highlighted with orange corre-
sponding to the four-helix domain and blue corresponding to the five-helix domain. (B) Tree diagram representing TLNRD1 presence and absence over ev-
olution. TLNRD1 first appears in choanoflagellates and sponges and is conserved throughout vertebrate evolution. TLNRD1 has been lost from nematodes,
arthropods, and Cnidaria. (C) TLNRD1-FL sequence conservation mapped onto the full-length TLNRD1 structure using ConSurf (Ashkenazy et al., 2016).
Structure colored according to extent of conservation with blue indicating variability and purple indicating highly conserved residues. Residues important for
dimerization (Q213, R246, F250, A260, and E267) are highlighted.
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Figure S2. Biochemical analysis of TLNRD1. (A) CD spectra of TLNRD1-FL (black) and TLNRD1-F250D (red) showing no change in overall secondary
structure as a result of the mutation. (B) nNMR analysis of the F250D mutant shows it closely resembles the WT. 1H,15N heteronuclear single quantum
coherence (HSQC) spectra of 150 µM 15N-labeled TLNRD1–4H WT (black) or TLNRD1-4H-F250D (red). (C) CD thermostability analysis of TLNRD1-FL and
TLNRD1-F250D showing a reduction in stability with loss of dimerization. (D) Binding of fluorescein-labeled RIAM (residues 4–30) peptide with TLNRD1-FLWT
(black) and TLNRD1-FL F250D (red) measured using a fluorescence polarization assay. (E) Low-speed actin cosedimentation bundling assay with TLNRD1-4H
serial dilution against 15 µM F-actin. The two gels show the (left) pellet and (right) supernatant fractions. At high TLNRD1-4H concentrations, unbound
TLNRD1-4H is present in the supernatant, suggesting the binding becomes saturated. At low TLNRD1-4H concentrations, the actin is predominantly in the
supernatant. (F) Actin filaments alone visualized by negative stain EM. (G and H) Actin binding of the F250D mutant. (G) High-speed actin binding assay of
TLNRD1-FL and TLNRD1-F250D showing little impact on actin binding with loss of dimerization. (H) Low-speed actin cosedimentation assay showing loss of
TLNRD1 actin bundling with loss of dimerization as a result of the F250D mutation. (I and J) SAXS analysis of TLNRD1 shows compact domain arrangement in
solution. (I) SAXS envelope reconstruction with GASBOR, showing the best fit with the TLNRD1-FL crystal structure. (J) Top-down view of I. MRE, molar
residue ellipticity; deg., degrees; NH, amide.
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Video 1. TLNRD1 can localize to actin fibers in living cells. U2OS cells expressing GFP-TLNRD1 were plated on fibronectin, incubated for 2 h with SiR-actin
to label the actin cytoskeleton, and imaged live using an Airyscan confocal microscope (1 picture every 16 s).
Figure S3. TLNRD1 localizes to the tip of MYO10 filopodia. U2OS cells expressing MYO10-mScarlet and GFP-TLNRD1 or GFP-TLNRD1-F250D were plated
on fibronectin for 2 h, stained for F-actin, and imaged using SIM. (A) Representative maximum intensity projections are displayed. The yellow squares highlight
regions of interest, which are magnified; scale bars: (main) 10 µm; (inset) 5 µm. (B) Heatmap highlighting the subcellular localization of F-actin, MYO10,
TLNRD1, and TLNRD1-F250Dwithin filopodia based on >360 intensity profiles (seeMaterials and methods for details). (C) Random 2Dmigration assay of U2OS
cells plated on fibronectin and nontransfected or transiently expressing GFP or GFP-TLNRD1. GFP-TLNRD1 overexpression increases migration velocity in 2D
(n = 120 cells from three independent repeats; ***, P < 0.001). Cell trajectories for nontransfected and GFP-TLNRD1–expressing cells are shown. P values were
determined using a randomization test (see Materials and methods for details).
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Table S1 is provided online as a separate file. Table S1 shows data collection and refinement statistics for TLNRD1-FL and
TLNRD1-4H domains.
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